Evidence map›Paper›PMID 23089196›Full record

ArticleCellular immunology2012

Impact of beta 2-microglobulin on tapasin expression and covalent association.

Laura C Simone, Brittney L Smith, Joyce C Solheim

Abstract read
In one paragraph

Article in Cellular immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Laura C SimoneEppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Brittney L Smith
Joyce C Solheim
University of Nebraska Medical Center · US

Funding

SUPPRESSIVE ROLE OF TGFBETA IN METASTASIS OF COLON CANCERP20RR018759 · NCRR · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI WAHL, JAMES K · 2003 to 2011
$17.9M
CHEMICAL CARCINOGENESIS &CANCER BIOLOGYT32CA009476 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Jennifer D. Black · 1988 to 2026
$6.2M
Nebraska Center for Cellular SignalingP20GM103489 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI JOHNSON, KEITH R · 2012 to 2012
$2.0M
ER PROTEINS EFFECT ON CLASS I MHC ASSEMBLYR01GM057428 · NIGMS · UNIVERSITY OF SOUTH DAKOTA · PI SOLHEIM, JOYCE C · 1998 to 2009
$1.5M
NCI NIH HHS T32 CA009476NCRR NIH HHS P20 RR018759NCRR NIH HHS P20 RR18759NIGMS NIH HHS GM057428-09S1NIGMS NIH HHS P20 GM103489NIGMS NIH HHS R01 GM057428
6 · The paper itself

Abstract

Cellular immunity is dependent on major histocompatibility complex (MHC) class I molecules enabling cytotoxic T cell recognition of malignant and infected cells. Loading of antigenic peptides onto MHC class I is assisted by a peptide-loading protein complex including tapasin. We found that tapasin expression is enhanced by beta 2-microglobulin via both transcriptional and post-transcriptional mechanisms. In addition, using conditions which preserve the tapasin-ERp57 disulfide-bonded conjugate, we demonstrated that beta 2-microglobulin increases tapasin-containing protein complexes, and reduces the level of MHC class I/ERp57 complexes lacking tapasin. Overall, our results provide a new perspective on the regulation of tapasin expression and association.

Indexed as

Animalsbeta 2-MicroglobulinBlotting, WesternCell Line, TumorDisulfidesGene ExpressionHistocompatibility Antigens Class IHumansMembrane Transport ProteinsMiceProtein BindingProtein Disulfide-IsomerasesReverse Transcriptase Polymerase Chain Reactionbeta 2-MicroglobulinDisulfidesHistocompatibility Antigens Class IMembrane Transport ProteinsPdia3 protein, mouseProtein Disulfide-Isomerasestapasin

Identifiers

PMID23089196
PMCPMC3518554
OpenAlexW2080571294

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.